Top compounds associated with response to SPECC1L


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA phloretin CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV